Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Cobalt-catalysed C–H methylation for late-stage drug diversification

Nature Chemistry volume 12, pages 511–519 (2020)Cite this article

Subjects

Abstract

The magic methyl effect is well acknowledged in medicinal chemistry, but despite its significance, accessing such analogues via derivatization at a late stage remains a pivotal challenge. In an effort to mitigate this major limitation, we here present a strategy for the cobalt-catalysed late-stage C–H methylation of structurally complex drug molecules. Enabling broad applicability, the transformation relies on a boron-based methyl source and takes advantage of inherently present functional groups to guide the C–H activation. The relative reactivity observed for distinct classes of functionalities were determined and the sensitivity of the transformation towards a panel of common functional motifs was tested under various reaction conditions. Without the need for prefunctionalization or postdeprotection, a diverse array of marketed drug molecules and natural products could be methylated in a predictable manner. Subsequent physicochemical and biological testing confirmed the magnitude with which this seemingly minor structural change can affect important drug properties.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Realizing a C–H activation–methylation protocol for LSF.
Fig. 2: Competition experiment that ranked different common functional groups as directing groups for the cobalt-catalysed C–H methylation with trimethylboroxine.
Fig. 3: Effect exerted by additives on the C–H methylation reaction under various conditions.
Fig. 4: Application of cobalt-mediated C–H methylation for LSF of biologically active substrates.
Fig. 5: Modulation of pharmaceutically relevant properties on C–H methylation.

Similar content being viewed by others

Data availability

Data, which include experimental procedures, references that support Fig. 1b, physicochemical, DMPK and pharmacological activity data for selected compounds, de novo synthesis strategies and NMR spectra, are available in the Supplementary Information.

References

  1. Bergman, R. G. Organometallic chemistry: CH activation. Nature 446, 391–393 (2007).

    Article  CAS  Google Scholar 

  2. Cernak, T., Dykstra, K. D., Tyagarajan, S., Vachal, R. & Krska, S. W. The medicinal chemist’s toolbox for late stage functionalization of drug-like molecules. Chem. Soc. Rev. 45, 546–576 (2016).

    Article  CAS  Google Scholar 

  3. Wencel-Delord, J. & Glorius, F. C–H bond activation enables the rapid construction and late-stage diversification of functional molecules. Nat. Chem. 5, 369–375 (2013).

    Article  CAS  Google Scholar 

  4. Larsen, M. A. & Hartwig, J. F. Iridium-catalyzed C–H borylation of heteroarenes: scope, regioselectivity, application to late-stage functionalization, and mechanism. J. Am. Chem. Soc. 136, 4287–4299 (2014).

    Article  CAS  Google Scholar 

  5. Berger, F. et al. Site-selective and versatile aromatic C–H functionalization by thianthrenation. Nature 567, 223–228 (2019).

    Article  CAS  Google Scholar 

  6. Saint-Denis, T. G., Zhu, R.-Y., Chen, G., Wu, Q.-F. & Yu, J.-Q. Enantioselective C(sp 3)–H bond activation by chiral transition metal catalysts. Science 359, eaao4798 (2018).

    Article  Google Scholar 

  7. Topczewski, J. J., Cabrera, P. J., Saper, N. I. & Sanford, M. S. Palladium-catalysed transannular C–H functionalization of alicyclic amines. Nature 531, 220–224 (2016).

    Article  CAS  Google Scholar 

  8. Liao, K. et al. Design of catalysts for site-selective and enantioselective functionalization of non-activated primary C–H bonds. Nat. Chem. 10, 1048–1055 (2018).

    Article  CAS  Google Scholar 

  9. Willcox, D. et al. A general catalytic β-C–H carbonylation of aliphatic amines to β-lactams. Science 354, 851–857 (2016).

    Article  CAS  Google Scholar 

  10. Hong, S. Y. et al. Selective formation of γ-lactams via C–H amidation enabled by tailored iridium catalysts. Science 359, 1016–1021 (2018).

    Article  CAS  Google Scholar 

  11. Barreiro, E. J., Kümmerle, A. E. & Fraga, C. A. M. The methylation effect in medicinal chemistry. Chem. Rev. 111, 5215–5246 (2011).

    Article  CAS  Google Scholar 

  12. Schönherr, H. & Cernak, T. Profound methyl effects in drug discovery and a call for new C–H methylation reactions. Angew. Chem. Int. Ed. 52, 12256–12267 (2013).

    Article  Google Scholar 

  13. Li, C., Liang, Y., Evans, R. W., Li, X. & MacMillan, D. W. C. Selective sp 3 C–H alkylation via polarity-match-based cross-coupling. Nature 547, 79–83 (2017).

  14. He, Z.-T., Li, H., Haydl, A. M., Whiteker, G. T. & Hartwig, J. F. Trimethylphosphate as a methylating agent for cross coupling: a slow-release mechanism for the methylation of arylboronic esters. J. Am. Chem. Soc. 140, 17197–17202 (2018).

    Article  CAS  Google Scholar 

  15. Daugulis, O., Roane, J. & Tran, L. D. Bidentate, monoanionic auxiliary-directed functionalization of carbon–hydrogen bonds. Acc. Chem. Res. 48, 1053–1064 (2015).

    Article  CAS  Google Scholar 

  16. Rouquet, G. & Chatani, N. Catalytic functionalization of C(sp 2)–H and C(sp 3)–H bonds by using bidentate directing groups. Angew. Chem. Int. Ed. 52, 11726–11743 (2013).

    Article  CAS  Google Scholar 

  17. Gandeepan, P. et al. 3d transition metals for C–H activation. Chem. Rev. 119, 2192–2452 (2019).

    Article  CAS  Google Scholar 

  18. Evano, G. & Theunissen, C. Beyond Friedel and Crafts: directed alkylation of C–H bonds in arenes. Angew. Chem. Int. Ed. 58, 2–37 (2019).

    Article  Google Scholar 

  19. Chen, Z. et al. Transition metal-catalyzed C–H bond functionalizations by the use of diverse directing groups. Org. Chem. Front. 2, 1107–1295 (2015).

    Article  CAS  Google Scholar 

  20. Graczyk, K., Haven, T. & Ackermann, L. Iron-catalyzed C(sp 2)–H and C(sp 3)–H methylations of amides and anilides. Chem. Eur. J. 21, 8812–8815 (2015).

    Article  CAS  Google Scholar 

  21. Shang, R., Ilies, L. & Nakamura, E. Iron-catalyzed ortho C–H methylation of aromatics bearing a simple carbonyl group with methylaluminum and tridentate phosphine ligand. J. Am. Chem. Soc. 138, 10132–10135 (2016).

    Article  CAS  Google Scholar 

  22. Thuy-Boun, P. S. et al. Ligand-accelerated ortho-C–H alkylation of arylcarboxylic acids using alkyl boron reagents. J. Am. Chem. Soc. 135, 17508–17513 (2013).

    Article  CAS  Google Scholar 

  23. Neufeldt, S. R., Seigerman, C. K. & Sanford, M. S. Mild palladium-catalyzed C–H alkylation using potassium alkyltrifluoroborates in combination with MnF3. Org. Lett. 15, 2302–2305 (2013).

    Article  CAS  Google Scholar 

  24. Rosen, B. R. et al. C–H functionalization logic enables synthesis of (+)-hongoquercin A and related compounds. Angew. Chem. Int. Ed. 52, 7317–7320 (2013).

    Article  CAS  Google Scholar 

  25. Yoshino, T. & Matsunaga, S. (Pentamethylcyclopentadienyl)cobalt(iii)-catalyzed C–H bond functionalization: from discovery to unique reactivity and selectivity. Adv. Synth. Catal. 359, 1245–1262 (2017).

    Article  CAS  Google Scholar 

  26. Moselage, M., Li, J. & Ackermann, L. Cobalt-catalyzed C–H activation. ACS Catal. 6, 498–525 (2016).

    Article  CAS  Google Scholar 

  27. Weissman, S. A. & Anderson, N. G. Design of experiments (DoE) and process optimization. A review of recent publications. Org. Process Res. Dev. 19, 1605–1633 (2015).

    Article  CAS  Google Scholar 

  28. Santanilla, A. B. et al. Nanomole-scale high-throughput chemistry for the synthesis of complex molecules. Science 347, 49–53 (2015).

    Article  Google Scholar 

  29. Tu, N. P. et al. High-throughput reaction screening with nanomoles of solid reagents coated on glass beads. Angew. Chem. Int. Ed. 58, 7987–7991 (2019).

    Article  CAS  Google Scholar 

  30. Gesmundo, N. J. et al. Nanoscale synthesis and affinity ranking. Nature 557, 228–332 (2018).

    Article  CAS  Google Scholar 

  31. Sambiagio, C. et al. A comprehensive overview of directing groups applied in metal-catalysed C–H functionalization chemistry. Chem. Soc. Rev. 47, 6603–6743 (2018).

    Article  CAS  Google Scholar 

  32. Tomberg, A. et al. Relative strength of common directing groups in palladium-catalyzed aromatic C–H activation. iScience 20, 373–391 (2019).

    Article  CAS  Google Scholar 

  33. Collins, K. D. & Glorius, F. A robustness screen for the rapid assessment of chemical reactions. Nat. Chem. 5, 597–601 (2013).

    Article  CAS  Google Scholar 

  34. Kutchukian, P. S. et al. Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods. Chem. Sci. 7, 2604–2613 (2016).

    Article  CAS  Google Scholar 

  35. Smith, J. M., Dixon, J. A., deGruyter, J. N. & Baran, P. S. Alkyl sulfinates: radical precursors enabling drug discovery. J. Med. Chem. 62, 2256–2264 (2019).

    Article  CAS  Google Scholar 

  36. Uehling, M. R., King, R. P., Krska, S. W., Cernak, T. & Buchwald, S. L. Pharmaceutical diversification via palladium oxidative addition complexes. Science 363, 405–408 (2019).

    Article  CAS  Google Scholar 

  37. Dai, H.-X., Stepan, A. F., Plummer, M. S., Zhang, Y.-H. & Yu, J.-Q. Divergent C–H functionalizations directed by sulfonamide pharmacophores: late-stage diversification as a tool for drug discovery. J. Am. Chem. Soc. 133, 7222–7228 (2011).

    Article  CAS  Google Scholar 

  38. Blakemore, D. C. et al. Organic synthesis provides opportunities to transform drug discovery. Nat. Chem. 10, 383–394 (2018).

  39. Bäurle, S. et al. Identification of a benzimidazolecarboxylic acid derivative (BAY 1316957) as a potent and selective human prostaglandin E2 receptor subtype 4 (hEP4-R) antagonist for the treatment of endometriosis. J. Med. Chem. 62, 2541–2563 (2019).

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank R. Sheppard and M. A. Hayes for valuable insight on biological testing, M. Härslätt and A. Ristinmaa for purification support, and M. A. Hayes and M. Lemurell for advice on the preparation of this manuscript. S.D.F. and M.J.J. acknowledge AstraZeneca and the AstraZeneca PostDoc program for their financial support. L.A. acknowledges the Georg-August-Universität Göttingen.

Author information

Authors and Affiliations

  1. Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

    Stig D. Friis & Magnus J. Johansson

  2. Institut für Organische und Biomolekulare Chemie, Georg-August-Universität Göttingen, Göttingen, Germany

    Lutz Ackermann

Authors
  1. Stig D. Friis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Magnus J. Johansson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lutz Ackermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S.D.F., M.J.J. and L.A. conceived the project and designed the experiments. M.J.J. and L.A. directed the project. S.D.F performed and analysed the experiments. S.D.F., M.J.J. and L.A. prepared the manuscript.

Corresponding authors

Correspondence to Magnus J. Johansson or Lutz Ackermann.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Experimental protocols and characterization for compounds mentioned in this work, references supporting Fig. 1b, overview of reaction optimization, description of competition experiments and compatibility screening, de novo synthesis strategies, PhysChem-, DMPK- and pharmacological activity data for selected compound and NMR spectra..

Reporting Summary

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Friis, S.D., Johansson, M.J. & Ackermann, L. Cobalt-catalysed C–H methylation for late-stage drug diversification. Nat. Chem. 12, 511–519 (2020). https://doi.org/10.1038/s41557-020-0475-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41557-020-0475-7

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing